Company news

Tarsus Pharmaceuticals, Inc. news in 2025

Tarsus Pharmaceuticals, Inc.'s news releases, calls and decks from 2025, newest first.

View company

Tarsus to Participate in Upcoming Investor Conference

November 23, 2025

Tarsus Reports Third Quarter 2025 Financial Results and Recent Business Achievements

November 3, 2025

Tarsus to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025

October 27, 2025

Tarsus to Participate in Upcoming Investor Conferences

August 26, 2025

Tarsus Reports Second Quarter 2025 Financial Results and Recent Business Achievements

August 5, 2025

Tarsus to Report Second Quarter 2025 Financial Results on Wednesday, August 6, 2025

July 29, 2025

Tarsus Reports First Quarter 2025 Financial Results and Recent Business Achievements

April 30, 2025

Tarsus to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025

April 23, 2025

Tarsus to Present Several Scientific Abstracts Highlighting the Global Prevalence of Demodex Blepharitis and the Clinical Impact of XDEMVY at the American Society of Cataract and Refractive Surgery (ASCRS) 2025 Annual Meeting

April 21, 2025

Tarsus Announces Proposed $100.0 Million Public Offering

March 11, 2025

Tarsus Announces Pricing of Upsized $125.0 Million Public Offering

March 11, 2025

Tarsus Reports Strong Fourth Quarter and Full-Year 2024 Financial Results and Recent Business Achievements

February 24, 2025

Tarsus to Report Fourth Quarter and Full-Year 2024 Financial Results on Tuesday, February 25, 2025

February 19, 2025

Tarsus Provides 2025 Update: Accelerating the Launch of XDEMVY® and Establishing Ocular Rosacea as the Next Category-Creating Opportunity in Eye Care

January 12, 2025

Calls in 2025

Decks in 2025